Zum Hauptinhalt springen

Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.

Qi, Y ; Klyubin, I ; et al.
In: Acta neuropathologica communications, Jg. 2 (2014-12-24), S. 175
Online academicJournal

Titel:
Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.
Autor/in / Beteiligte Person: Qi, Y ; Klyubin, I ; Harney, SC ; Hu, N ; Cullen, WK ; Grant, MK ; Steffen, J ; Wilson, EN ; Do Carmo, S ; Remy, S ; Fuhrmann, M ; Ashe, KH ; Cuello, AC ; Rowan, MJ
Link:
Zeitschrift: Acta neuropathologica communications, Jg. 2 (2014-12-24), S. 175
Veröffentlichung: London : BioMed Central, [2013]-, 2014
Medientyp: academicJournal
ISSN: 2051-5960 (electronic)
DOI: 10.1186/s40478-014-0175-x
Schlagwort:
  • Age Factors
  • Alzheimer Disease physiopathology
  • Amyloid Precursor Protein Secretases antagonists & inhibitors
  • Amyloid beta-Peptides immunology
  • Amyloid beta-Protein Precursor genetics
  • Amyloid beta-Protein Precursor immunology
  • Animals
  • Antibodies pharmacology
  • Aspartic Acid Endopeptidases antagonists & inhibitors
  • Behavior, Animal physiology
  • Disease Models, Animal
  • Heterocyclic Compounds, 2-Ring pharmacology
  • Hippocampus drug effects
  • Hippocampus metabolism
  • Humans
  • Long-Term Potentiation drug effects
  • Male
  • Picolinic Acids pharmacology
  • Rats
  • Rats, Transgenic
  • Rats, Wistar
  • Sulfonamides pharmacology
  • Synaptic Transmission drug effects
  • Amyloid beta-Peptides metabolism
  • Hippocampus physiopathology
  • Long-Term Potentiation physiology
  • Synaptic Transmission physiology
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • Language: English
  • [Acta Neuropathol Commun] 2014 Dec 24; Vol. 2, pp. 175. <i>Date of Electronic Publication: </i>2014 Dec 24.
  • MeSH Terms: Amyloid beta-Peptides / *metabolism ; Hippocampus / *physiopathology ; Long-Term Potentiation / *physiology ; Synaptic Transmission / *physiology ; Age Factors ; Alzheimer Disease / physiopathology ; Amyloid Precursor Protein Secretases / antagonists & inhibitors ; Amyloid beta-Peptides / immunology ; Amyloid beta-Protein Precursor / genetics ; Amyloid beta-Protein Precursor / immunology ; Animals ; Antibodies / pharmacology ; Aspartic Acid Endopeptidases / antagonists & inhibitors ; Behavior, Animal / physiology ; Disease Models, Animal ; Heterocyclic Compounds, 2-Ring / pharmacology ; Hippocampus / drug effects ; Hippocampus / metabolism ; Humans ; Long-Term Potentiation / drug effects ; Male ; Picolinic Acids / pharmacology ; Rats ; Rats, Transgenic ; Rats, Wistar ; Sulfonamides / pharmacology ; Synaptic Transmission / drug effects
  • References: Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20504-9. (PMID: 19918059) ; Neurobiol Dis. 2008 Jul;31(1):46-57. (PMID: 18504134) ; Hippocampus. 2010 Jun;20(6):758-67. (PMID: 19623539) ; Philos Trans R Soc Lond B Biol Sci. 2014 Jan 5;369(1633):20130147. (PMID: 24298149) ; Philos Trans R Soc Lond B Biol Sci. 2014 Jan 5;369(1633):20130131. (PMID: 24298134) ; J Neurosci. 2010 Aug 18;30(33):11157-66. (PMID: 20720123) ; Mol Neurodegener. 2013;8:37. (PMID: 24161192) ; Mol Neurobiol. 2012 Dec;46(3):572-87. (PMID: 22914888) ; Philos Trans R Soc Lond B Biol Sci. 2014 Jan 5;369(1633):20130163. (PMID: 24298164) ; Front Behav Neurosci. 2014 Sep 16;8:321. (PMID: 25278855) ; Brain. 2013 May;136(Pt 5):1383-98. (PMID: 23576130) ; Lancet Neurol. 2014 Jun;13(6):614-29. (PMID: 24849862) ; J Pharmacol Exp Ther. 2010 Apr;333(1):110-9. (PMID: 20056779) ; Hippocampus. 1992 Oct;2(4):373-88. (PMID: 1364048) ; Cereb Cortex. 2013 Apr;23(4):932-9. (PMID: 22490551) ; Neurobiol Aging. 2014 Jan;35(1):88-95. (PMID: 23932880) ; J Neurosci. 2011 May 4;31(18):6627-38. (PMID: 21543591) ; Neuroreport. 1997 Oct 20;8(15):3213-7. (PMID: 9351645) ; Nature. 2009 Feb 26;457(7233):1128-32. (PMID: 19242475) ; Brain Res. 1989 Nov 27;503(1):148-51. (PMID: 2575432) ; Nat Neurosci. 2005 Aug;8(8):1051-8. (PMID: 16025111) ; Neuropharmacology. 2010 Sep-Oct;59(4-5):243-67. (PMID: 20167227) ; Brain Res. 2003 Apr 11;968(2):263-72. (PMID: 12663096) ; Mol Brain. 2012;5:25. (PMID: 22805374) ; Nature. 2011 Jan 6;469(7328):47-52. (PMID: 21113149) ; Brain. 2008 Sep;131(Pt 9):2414-24. (PMID: 18678563) ; Neuropharmacology. 2008 Aug;55(2):175-82. (PMID: 18538800) ; Neuron. 2014 Mar 19;81(6):1274-81. (PMID: 24560703) ; Hum Mol Genet. 2009 Dec 1;18(23):4492-500. (PMID: 19744962) ; J Biol Chem. 2000 Feb 25;275(8):5626-32. (PMID: 10681545) ; Neurobiol Aging. 2014 Oct;35(10):2249-62. (PMID: 24831823) ; Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338. (PMID: 22762015) ; Neurobiol Dis. 2008 Jun;30(3):439-50. (PMID: 18442916) ; J Alzheimers Dis. 2010;20(1):113-26. (PMID: 20164597) ; J Neurosci. 2013 Feb 27;33(9):3765-79. (PMID: 23447589) ; Neurobiol Aging. 2015 Jan;36(1):123-33. (PMID: 25104560) ; Nat Neurosci. 2012 Sep;15(9):1227-35. (PMID: 22820466) ; Neurobiol Aging. 2011 Dec;32(12):2219-28. (PMID: 20133015) ; J Neurosci. 2014 Jun 4;34(23):7871-85. (PMID: 24899710) ; Nature. 2006 Mar 16;440(7082):352-7. (PMID: 16541076) ; J Alzheimers Dis. 2000 Nov;2(3-4):207-22. (PMID: 12214085) ; JAMA Neurol. 2013 May;70(5):594-9. (PMID: 23479202) ; J Alzheimers Dis. 2012;32(1):183-96. (PMID: 22785392) ; J Neurosci. 1996 Jan;16(1):418-24. (PMID: 8613807) ; Acta Neuropathol Commun. 2014;2:61. (PMID: 24903713) ; PLoS One. 2014;9(3):e91203. (PMID: 24621690) ; J Neurosci. 2005 Sep 28;25(39):8898-902. (PMID: 16192379) ; Alzheimers Dement. 2013 Mar;9(2):99-112. (PMID: 23375565) ; J Neurosci. 2002 Aug 1;22(15):6331-5. (PMID: 12151510) ; Nat Neurosci. 2002 May;5(5):452-7. (PMID: 11941374) ; Neurobiol Aging. 2009 Feb;30(2):241-56. (PMID: 17673336) ; J Immunol Methods. 2008 Apr 20;333(1-2):156-66. (PMID: 18313069)
  • Grant Information: R01 NS033249 United States NS NINDS NIH HHS; MOP 102752 Canada Canadian Institutes of Health Research; R01-NS33249 United States NS NINDS NIH HHS
  • Substance Nomenclature: 0 (Amyloid beta-Peptides) ; 0 (Amyloid beta-Protein Precursor) ; 0 (Antibodies) ; 0 (Heterocyclic Compounds, 2-Ring) ; 0 (MRK 560) ; 0 (N-(3-(2-amino-4a,5,7,7a-tetrahydro-4H-furo(3,4-d)(1,3)thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinamide) ; 0 (Picolinic Acids) ; 0 (Sulfonamides) ; EC 3.4.- (Amyloid Precursor Protein Secretases) ; EC 3.4.23.- (Aspartic Acid Endopeptidases) ; EC 3.4.23.46 (Bace1 protein, rat)
  • Entry Date(s): Date Created: 20141226 Date Completed: 20150529 Latest Revision: 20191210
  • Update Code: 20231215
  • PubMed Central ID: PMC4293804

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -